ASH abstract_CD38 x ICAM1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and LymphomaNovember 11, 2021/by eallisonASH abstract_CD38 x ICAM1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma /wp-content/uploads/Virtuoso_Logo.png 0 0 eallison /wp-content/uploads/Virtuoso_Logo.png eallison2021-11-11 15:09:232021-11-11 15:09:23ASH abstract_CD38 x ICAM1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
